🏛️ Verified NIH Record • Updated 2025-12-04
A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults (NCT06967181)
A Phase 1 Trial of CVM150 and CVM26 Intranasal Mumps Virus Vaccines in Healthy Adults
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: CyanVac LLC
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this trial is to evaluate the safety and immunogenicity of CVM150 and CVM26. The trial will enroll up to 60 healthy participants.
Who can join: Review the eligibility criteria below.
Location: University Of Rochester Medical Center — Rochester, New York
Age range: 18 Years to 29 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- University Of Rochester Medical Center — Rochester, New York
- Cincinnati Children's Hospital Medical Center Vaccine Research Center — Cincinnati, Ohio
- Coastal Carolina Research Center — North Charleston, South Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Mumps clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.